-
OFF-LABEL USE AND ADHERENCE TO GLP-1S AS ADJUNCT THERAPY IN TYPE 1 DIABETES: A COMPARATIVE ANALYSIS VERSUS METFORMIN
Mar 18, 2026, 21:38 PM -
ANALYSING THE IMPACT OF SHARED DECISION MAKING AMONGST CANCER PATIENTS ON TOTAL MEDICAL EXPENDITURE BY PAYER TYPE AND NUMBER OF EMERGENCY VISITS
Mar 18, 2026, 21:38 PM -
POTENTIAL BENEFITS OF RSV VACCINATION IN COLOMBIAN ADULTS AGED 60 AND OVER: A COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
REPORTING OF STUDY DETAILS IN ABSTRACTS: INFORMATIVE FOR ARTIFICIAL INTELLIGENCE (AI) OR UNDERWHELMING?
Mar 18, 2026, 21:38 PM -
IMPACT OF TELEMEDICINE ENCOUNTERS ON SURVIVAL OUTCOMES: A TIME-VARYING COX ANALYSIS USING EHR-DERIVED DATA
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARISON OF OLANZAPINE/SAMIDORPHAN VS OLANZAPINE: AN ASSESSMENT OF TREATMENT PATTERNS AND ACUTE CARE EVENTS AMONG PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
Mar 18, 2026, 21:38 PM -
BRIDGING EVIDENCE AND ACCESS: SURVEY-BASED INSIGHTS INTO HOW BIOPHARMACEUTICAL MANUFACTURERS DEVELOP AND SHARE HCEI RESOURCES
Mar 18, 2026, 21:38 PM -
THE VALUE VOCABULARY: AN ANALYSIS OF SOCIETAL TERMS IN CDA-AMC AND INESSS HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF RSV MATERNAL IMMUNIZATION [RSVPREF] IN THE DOMINICAN REPUBLIC: A COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
IMPACT OF PD-1 AND PD-L1 INHIBITORS ON PATIENT-REPORTED OUTCOMES IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
EXPLORING PHYSICIANS’ PERSPECTIVES ON BARRIERS TO ENGAGING PATIENTS WITH RARE DISEASES AND/OR THEIR CAREGIVERS IN SHARED DECISION-MAKING IN THE UNITED STATES (US): FINDINGS FROM A CROSS-SECTIONAL SURVEY
Mar 18, 2026, 21:38 PM -
DEFINING TREATMENT TOLERABILITY FROM THE PATIENT’S PERSPECTIVE: A MIXED-METHODS ANALYSIS OF THE CANCER EXPERIENCE REGISTRY
Mar 18, 2026, 21:38 PM -
INDIVIDUAL PREFERENCES FOR UPPER EXTREMITY PROSTHETICS ALONG A USER-COMPLEXITY FRAMEWORK: A DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
GEOSPATIAL EQUITY AND ECONOMIC IMPLICATIONS OF HEALTH DEVELOPMENT OFFICES IN HUNGARY
Mar 18, 2026, 21:38 PM -
LEVERAGING ARTIFICIAL INTELLIGENCE TO EXPEDITE DOSSIER DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
REAL-WORLD USE OF GENERATIVE AI ASSISTANT TOOLS ACROSS HEALTH ECONOMICS AND OUTCOMES RESEARCH WORKFLOWS: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
COST SAVINGS OF AN AI-ENABLED DIGITAL TWIN PROGRAM IN PREDIABETES AND HEALTHY WEIGHT MANAGEMENT
Mar 18, 2026, 21:38 PM -
REDUCING DECISION UNCERTAINTY IN ULTRA-RARE PEDIATRIC CONDITIONS: A DELPHI-BASED APPROACH TO INFORM HTA AND PRICING & REIMBURSEMENT FOR NON-DYSTROPHIC MYOTONIAS
Mar 18, 2026, 21:38 PM -
USE ARTIFICIAL INTELLIGENCE TO PREDICT REGULATORY APPROVAL BASED ON PHASE III ONCOLOGY CLINICAL TRIAL PUBLICATIONS
Mar 18, 2026, 21:38 PM -
EFFECT OF MENTAL HEALTH PARITY AND ADDICTION EQUITY ACT (MHPAEA) ON MENTAL HEALTH CARE UTILIZATION
Mar 18, 2026, 21:38 PM
